Agreed Max. Its tanking, there's no doubt. But I really like the...

Agreed Max. Its tanking, there's no doubt. But I really like the technology they hold and have acquired. Transgene with or without a partner will be moving TG4010 to Phase III, which will be one gigantic advert for Virax's Co-X-Gene technology. Taking the newly acquired GGTI-2418 to Phase II trials next year (i think) is also excellent progress.
At this stage, i have to ignore the big red mark on my portfolio and maybe pop this in a draw for 6-12 months. I'm confident things will turn around.